Immunohistochemistry (IHC) is the gold-standard technique for molecular phenotyping and subtype stratification in breast cancer diagnosis. However, conventional IHC staining is limited by high reagent costs, lengthy processing times, tissue consumption, and difficulty scaling for high-throughput screening. Because hematoxylin and eosin (H&E) staining provides rich morphological information, H&E-to-IHC cross-modal translation is a highly promising paradigm for cost-effective, non-destructive, and efficient molecular diagnosis. Nevertheless, existing methods still suffer from two critical bottlenecks, namely insufficient pathological semantics and non-rigid spatial misalignment. To overcome these challenges, we propose the Pathology-aware Brownian Bridge Diffusion Model (PABBDM). This framework integrates Brownian bridge diffusion dynamics, pathology-aware conditioning (PaC) injection, and a deformable U-Net for virtual IHC staining. The PaC encoder directly extracts anatomical and morphological priors from H&E in pixel space and injects them as spatial guidance into the deformable U-Net to maintain pathological semantic consistency throughout the denoising process. Furthermore, a composite loss function combining latent L1 reconstruction loss and patch-level contrastive loss is employed to jointly optimize pixel-level accuracy, structural fidelity, and perceptual consistency of biomarker expression. We validate PABBDM on two public breast cancer datasets, MIST and IHC4BC, covering four key clinical biomarkers (Ki67, ER, PR, HER2). On the IHC4BC dataset, PABBDM achieves SSIM values of 0.487, 0.599, 0.696, and 0.167 for Ki67, ER, PR, and HER2, respectively, with the lowest LPIPS of 0.198 on PR, outperforming mainstream GAN-based and original BBDM methods. Both quantitative and qualitative evaluations demonstrate that PABBDM effectively enhances the structural consistency, morphological fidelity, and perceptual realism of the generated IHC images, while better preserving biomarker expression patterns compared to baseline methods. The proposed method provides a promising virtual staining approach for efficient and cost-effective analysis in breast cancer histopathology.